Mirtazapine safety reporting in depression: meta-analysis


A systematic review of mirtazapine treatment trials has found that there is inadequate reporting of adverse events in therapeutic trials of major depression (Watanabe et al. CNS Drugs 2010; 24: 35-53).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page